Search
for
Sort by
Research 421–450 of 1000+
- P23 A case of visceral leishmaniasis presenting as seropositive erosive rheumatoid arthritis in an immunocompromised patient
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- eLife assessment: Decoding the complexity of delayed wound healing following Enterococcus faecalis infection
- Giant solitary trichoepithelioma: A rare trichogenic tumor
- Acute pancreatitis: An unusual presentation of systemic lupus erythematosus
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Diffuse hair loss in females
- Lifestyle drugs: concept and impact on society
- Stem Cell Secretome for Skincare: Of Cell Types, Exosomes, Extracellular Vesicles, and Soluble Fractions
- Editorial: Untangle the broad connections and tight interactions between human microbiota and complex diseases through data-driven approaches, volume II
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Interventions for central serous chorioretinopathy: a network meta-analysis
- Trained Immunity and Local Innate Immune Memory in the Lung
- Advancements and challenges in stem cell transplantation for regenerative medicine
- Natural Bizbenzoquinoline Derivatives Protect Zebrafish Lateral Line Sensory Hair Cells from Aminoglycoside Toxicity
- Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review
- Efficacy of Platelet-Rich Plasma Therapy in Oral Lichen Planus: A Systematic Review
- Hormonal trends in patients suffering from long COVID symptoms
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Colchicine in Managing Skin Conditions: A Systematic Review
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Observation on cadavers and through ultrasonography using a 2 mm needle length for intradermal injections
- The Art of Building Living Tissues: Exploring the Frontiers of Biofabrication with 3D Bioprinting
- Angiogenic factor-driven improvement of refractory thin endometrium with autologous platelet-rich plasma intrauterine infusion in frozen embryo transfer cycles
- A quantitative technique to analyze and evaluate microstructures of skin hair follicles based on mueller matrix polarimetry
- Ruxolitinib found to cause eyelash growth: a case report
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician